BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37983375)

  • 1. Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models.
    Sofia RD; Martin KM; Costin JC
    Anticancer Drugs; 2024 Feb; 35(2):183-189. PubMed ID: 37983375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.
    Li G; Yu K; Li F; Xu K; Li J; He S; Cao S; Tan G
    J Ethnopharmacol; 2014 Apr; 153(2):521-30. PubMed ID: 24631140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
    Garrett LA; Growdon WB; Rueda BR; Foster R
    J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models.
    Spychala J
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6501-6511. PubMed ID: 36780052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
    Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
    World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31.
    Sun W; Wong ILK; Law HK; Su X; Chan TCF; Sun G; Yang X; Wang X; Chan TH; Wan S; Chow LMC
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M; Hasegawa A; Yamamori M; Okamura N
    J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models.
    Joshi KS; Rathos MJ; Mahajan P; Wagh V; Shenoy S; Bhatia D; Chile S; Sivakumar M; Maier A; Fiebig HH; Sharma S
    Mol Cancer Ther; 2007 Mar; 6(3):926-34. PubMed ID: 17363487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
    Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
    Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
    Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf).
    Suzuki H; Asano T; Ohishi T; Yoshikawa T; Suzuki H; Mizuno T; Tanaka T; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):34-40. PubMed ID: 36383106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.
    Lange TS; Stuckey AR; Robison K; Kim KK; Singh RK; Raker CA; Brard L
    Invest New Drugs; 2010 Oct; 28(5):543-53. PubMed ID: 19582372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
    Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
    Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and Phytochemical Properties of
    Elarabany N; Hamad A; Alzamel NM
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.